Get the Stockscreener App
28.06
2.16%
-0.62
After Hours:
28.10
0.04
+0.14%
Amphastar Pharmaceuticals Inc stock is traded at $28.06, with a volume of 273.49K.
It is down -2.16% in the last 24 hours and down -7.55% over the past month.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
See More
Previous Close:
$28.68
Open:
$28.86
24h Volume:
273.49K
Relative Volume:
0.53
Market Cap:
$1.30B
Revenue:
$722.68M
Net Income/Loss:
$134.71M
P/E Ratio:
10.51
EPS:
2.67
Net Cash Flow:
$109.94M
1W Performance:
-4.62%
1M Performance:
-7.55%
6M Performance:
+6.77%
1Y Performance:
-39.68%
1-Day Range:
$27.91
$28.86
1-Week Range:
$27.91
$29.43
52-Week Range:
$20.39
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Name
Amphastar Pharmaceuticals Inc
Sector
Phone
909-980-9484
Address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Compare AMPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
28.06 | 1.32B | 722.68M | 134.71M | 109.94M | 2.67 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-25 | Upgrade | Needham | Hold → Buy |
| May-12-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-04-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-22-24 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-24 | Initiated | JP Morgan | Overweight |
| Nov-17-23 | Initiated | BofA Securities | Neutral |
| Jul-25-23 | Resumed | Jefferies | Buy |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Jul-29-22 | Initiated | CapitalOne | Overweight |
| Jan-07-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-08-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-05-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| May-01-20 | Initiated | Northland Capital | Outperform |
| Mar-13-19 | Downgrade | Needham | Buy → Hold |
| Mar-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-10-18 | Reiterated | Needham | Buy |
| Mar-13-18 | Reiterated | Needham | Buy |
| Dec-01-17 | Reiterated | Needham | Buy |
| Nov-09-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-27-17 | Reiterated | Needham | Buy |
| Mar-14-17 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-09-16 | Reiterated | Needham | Buy |
| May-10-16 | Reiterated | Needham | Buy |
| Feb-19-16 | Initiated | Wells Fargo | Outperform |
| Jun-19-15 | Reiterated | Needham | Buy |
| Jun-03-15 | Initiated | Raymond James | Strong Buy |
| Jul-21-14 | Initiated | Needham | Buy |
View All
Amphastar Pharmaceuticals Inc Stock (AMPH) Latest News
Aristeia Capital L.L.C. Has $981,000 Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Is this a good reentry point in Amphastar Pharmaceuticals Inc.Market Risk Summary & Safe Capital Growth Trade Ideas - Newser
What MACD and RSI say about Amphastar Pharmaceuticals Inc.Watch List & Entry Point Confirmation Signals - Newser
Real time pattern detection on Amphastar Pharmaceuticals Inc. stockJuly 2025 Earnings & Trade Opportunity Analysis - Newser
Graham Capital Management L.P. Buys Shares of 26,424 Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals, Inc. $AMPH Shares Sold by Trexquant Investment LP - MarketBeat
A Fresh Look at Amphastar Pharmaceuticals (AMPH) Valuation After Recent Share Price Momentum - Yahoo Finance
CEO Moves: Will Amphastar Pharmaceuticals Inc. outperform the market in YEARJuly 2025 News Drivers & Technical Buy Zone Confirmation - Lancaster City Council
Amphastar Pharmaceuticals, Inc. (AMPH) Secures FDA Approval for Generic Iron Sucrose Injection - MSN
Amphastar Pharmaceuticals Inc. Breakout Confirmed by Volume Metrics2025 Trade Ideas & Real-Time Volume Trigger Notifications - beatles.ru
Northern Trust Corp Sells 18,733 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Will Amphastar Pharmaceuticals Inc. benefit from AI trends2025 Risk Factors & AI Driven Stock Reports - beatles.ru
Chart based exit strategy for Amphastar Pharmaceuticals Inc.Market Activity Summary & Capital Efficiency Focused Strategies - Newser
Will Amphastar Pharmaceuticals Inc. outperform small cap indexesStock Surge & Free Growth Oriented Trading Recommendations - خودرو بانک
Has Amphastar Pharmaceuticals Inc. found a price floor2025 Institutional Moves & Weekly High Return Stock Forecasts - Newser
Tools to monitor Amphastar Pharmaceuticals Inc. recovery probabilityJuly 2025 EndofMonth & Trade Opportunity Analysis Reports - Newser
What recovery options are there for Amphastar Pharmaceuticals Inc.July 2025 Fed Impact & Accurate Buy Signal Notifications - Newser
What analysts say about Amphastar Pharmaceuticals Inc. stockQuarterly Profit Review & Expert Verified Movement Alerts - خودرو بانک
Is now a turning point for Amphastar Pharmaceuticals Inc.2025 Technical Patterns & Expert Approved Momentum Ideas - Newser
Can Amphastar Pharmaceuticals Inc. stock double in the next yearEarnings Risk Summary & Reliable Volume Spike Alerts - خودرو بانک
Applying Wyckoff theory to Amphastar Pharmaceuticals Inc. stock2025 Winners & Losers & Weekly Return Optimization Alerts - Newser
Identifying reversal signals in Amphastar Pharmaceuticals Inc.Weekly Gains Summary & Weekly Sector Rotation Insights - Newser
What’s the recovery path for long term holders of Amphastar Pharmaceuticals Inc.Short Setup & Smart Swing Trading Alerts - Newser
What makes Amphastar Pharmaceuticals Inc. stock price move sharplyWeekly Trade Summary & Daily Volume Surge Signals - Newser
A Look Back at Generic Pharmaceuticals Stocks’ Q2 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Pack - Yahoo Finance
Risk adjusted return profile for Amphastar Pharmaceuticals Inc. analyzedJuly 2025 Setups & Risk Managed Investment Signals - Newser
Amphastar Pharmaceuticals Inc. stock trend outlook and recovery pathInsider Buying & Technical Confirmation Trade Alerts - Newser
Best data tools to analyze Amphastar Pharmaceuticals Inc. stockMarket Sentiment Report & Daily Momentum Trading Reports - Newser
What technical models suggest about Amphastar Pharmaceuticals Inc.’s comebackTrade Risk Assessment & AI Powered Market Entry Ideas - Newser
Forecasting Amphastar Pharmaceuticals Inc. price range with options dataDay Trade & Real-Time Price Movement Reports - Newser
Smart tools for monitoring Amphastar Pharmaceuticals Inc.’s price actionJuly 2025 Drop Watch & AI Optimized Trading Strategy Guides - Newser
Is Amphastar Pharmaceuticals Inc. being accumulated by smart moneyWeekly Stock Report & Low Volatility Stock Suggestions - خودرو بانک
Amphastar Pharmaceuticals Inc Stock (AMPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.67%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):